Tasigna - nilotinib
Navigation: NDC > Supplier starting with: N > NOVARTIS PHARMACEUTICALS CORPORATION| Field | Value |
|---|---|
| NDC Code: | 0078-0592 |
| Proprietary Name: | Tasigna |
| Suffix: | |
| Non-Proprietary Name: | nilotinib |
| Dosage Form: | CAPSULE |
| Method: | ORAL |
| Original Marketing Date: | 29-10-2007 |
| Category Name: | NDA |
| Application Number: | NDA022068 |
| Labeler: | NOVARTIS PHARMACEUTICALS CORPORATION |
| Substance Name: | NILOTINIB |
| Active Numerator Strength: | 150 |
| Active Ingredient Unit: | mg/1 |
| Pharm Classes: | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] |
| DEA Schedule: |